How the contract works
A contract on this question settles at $1 if Oura's market capitalization is at least $20 billion at the close of its first trading day, and at nothing if it is not, including if no IPO happens by the end of 2026. The price at any moment is simply the market's current estimate of that chance stated as a fraction of a dollar; a contract priced at 0.30, for example, would mean the market sees roughly a three-in-ten chance of that $20 billion threshold being cleared, not a prediction about this specific market. Settlement uses the closing share price and shares outstanding reported by Oura's primary listing exchange on its first trading day, or the next session with a published close if trading is halted. A position in this contract can typically be sold before that settlement date at whatever price the market is showing then, rather than held to the outcome.
Yes41%
No59%
Probability
How the price has moved
The only pricing data available comes from a single venue, Polymarket, with $31,775 in total volume, putting the consensus probability at 28%. No multi-day or multi-venue history has been established yet, so there is no reported move over the last day or week to describe, and no spread between venues to indicate disagreement. That should be read plainly: this is an early-stage, lightly traded price rather than one shaped by sustained competing views, and it is likely to move more on any single piece of news, such as a leaked filing, than a deeper market would.
Analysis
Context
Oura makes a titanium smart ring that tracks sleep, heart rate and recovery data, competing with Whoop and, indirectly, Apple Watch and Fitbit in the wearable health-tracking category. The company has built a strong consumer brand and has raised several rounds of private funding, reportedly valuing it near $5 billion in a 2025 round, but it has not filed public IPO paperwork or named a listing exchange or date as of this writing. This market exists purely on speculation about a future event: whether Oura goes public at all before the end of 2026, and if so, whether its first-day market capitalization clears $20 billion. Both conditions have to be met for a Yes outcome, and the settlement rules make that explicit by treating any failure to IPO by 31 December 2026 as a resolution reflecting no IPO having occurred.
The consensus reading across trading venues puts the probability of a Yes outcome at 28%, a figure produced by a single venue, Polymarket, on just $31,775 of total volume. That is a thin market by the standards of most tracked events, which means the 28% figure should be read as an early, lightly tested estimate rather than a number backed by deep, competing order flow. With only one venue pricing the contract, there is no spread between venues to check the estimate against, and no multi-day price history has been established yet to show whether sentiment is stable or still finding its level.
The core of the pricing logic is arithmetic rather than sentiment: Oura would need a first-day market capitalization roughly four times its last widely reported private valuation of around $5 billion. Private-to-public valuation jumps of that size happen, but they are the exception, not the rule, and they typically require strong revenue growth disclosed in an S-1 filing, a favorable IPO window, and comparable public companies trading at rich multiples. None of those three conditions can be confirmed yet because Oura has not filed to go public.
The resolution deadline compounds the uncertainty. Because the market resolves to reflect no IPO having occurred if none happens by 31 December 2026, 11:59 PM ET, the probability priced here is really the product of two separate uncertain events: whether Oura lists at all within roughly the next 16 months, and, conditional on listing, whether it prices high enough to clear $20 billion. A low combined probability is consistent with meaningful doubt on the first condition alone, since consumer hardware companies frequently delay listing plans in response to market conditions.
Historical comparables in wearable and health-tech IPOs offer a mixed signal: some consumer hardware names have listed at valuations well below their final private funding round, particularly when public market appetite for hardware margins is weaker than for software. That pattern argues against assuming Oura's IPO, if it happens, would automatically price at or above its last private mark, let alone quadruple it.
What moves the probability
No confirmed IPO filing
Oura has not filed an S-1 or named an exchange or date, which is the single largest source of uncertainty in this price. Until a filing appears, the market is pricing a hypothetical event rather than a scheduled one, which tends to keep probabilities well below the levels seen once a roadshow is underway.
Valuation gap to close
Oura's most recently reported private valuation was near $5 billion, meaning a $20 billion first-day market cap would require roughly a fourfold jump. That gap is large relative to typical private-to-public valuation moves and pulls the probability down.
31 December 2026 deadline
The settlement rules resolve this market to reflect no IPO occurring if none happens by year-end 2026. Any delay past that date, common among companies weighing market conditions, caps the Yes probability regardless of how Oura might eventually price.
Comparable hardware IPO pricing
How other recent consumer hardware and health-tech listings have priced relative to their last private round is a signal investors will watch. A strong comparable pricing above its private valuation would support a higher probability here; a weak one would reinforce the current pricing.
Thin, single-venue trading
With only $31,775 traded on one venue, the current 28% figure carries less weight than a price formed across multiple markets with deeper volume. New information, including any leaked filing details, could move the price sharply on light volume.
The case for
- Oura would need to file for an IPO before 31 December 2026 and price shares that value the company at $20 billion or more at the first day's close.
- Strong revenue growth disclosed in an S-1, combined with a favorable window for consumer health-tech listings, could support a valuation well above the last reported private round.
- A well-received roadshow with institutional demand exceeding supply could push the opening and closing price meaningfully higher than initial guidance.
- Comparable wearable or health-tech companies trading at rich public-market multiples could pull Oura's pricing upward by association.
The case against
- Oura has not filed an S-1 or confirmed a listing date, and if no IPO occurs by 31 December 2026 the market resolves as if none had happened, regardless of any later plans.
- The company's most recently reported private valuation was near $5 billion, meaning a $20 billion close would require close to a fourfold increase, an unusually large jump for a public debut.
- Consumer hardware companies have often listed at valuations at or below their last private funding round when public investors discount hardware margins relative to software.
- The pricing here comes from a single, thinly traded venue, which suggests the market has not yet been tested by enough capital to reflect a confident consensus.
What to watch
The clearest trigger for repricing would be Oura filing an S-1 or otherwise confirming a listing exchange and date, which would let the market weigh actual revenue and share-count disclosures rather than speculation. Any reported update to Oura's private valuation ahead of a listing would also matter, since it is the baseline this $20 billion threshold is measured against. More broadly, how other consumer hardware or health-tech IPOs price through 2026 will serve as a comparable signal. The hard deadline is 31 December 2026, 11:59 PM ET; absent a confirmed IPO by then, the market resolves to reflect no listing having occurred.
Trade this contract
Open on Polymarket
- gas covered
